CELLCURA
LIVE

Serial Number

99302295

Owner

Cellcura Sciences, Inc.

Attorney

Cy Bates

Filing Date

Jul 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CELLCURA Trademark

Serial Number: 99302295

CELLCURA is a trademark filed by Cellcura Sciences, Inc. on July 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Cellcura Sciences, Inc. (3 trademarks)

3400 W Mayflower Ave. Suite 122
Lehi, UT 84043

Entity Type: 03

Trademark Details

Filing Date

July 25, 2025

Registration Date

Not Registered

Published for Opposition

February 24, 2026

Goods & Services

Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 25, 2025 MAFR
NEW APPLICATION ENTERED
Jul 25, 2025 NWAP